BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 29804294)

  • 21. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.
    Tsay FW; Tseng HH; Hsu PI; Wang KM; Lee CC; Chang SN; Wang HM; Yu HC; Chen WC; Peng NJ; Lai KH; Wu DC
    J Gastroenterol Hepatol; 2012 Mar; 27(3):498-503. PubMed ID: 21871025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 14-day course of triple therapy is superior to a 10-day course for the eradication of Helicobacter pylori: A Canadian study conducted in a 'real world' setting.
    Chen YI; Fallone CA
    Can J Gastroenterol Hepatol; 2015; 29(8):e7-10. PubMed ID: 26301332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Kawai T; Takahashi S; Suzuki H; Sasaki H; Nagahara A; Asaoka D; Matsuhisa T; Masaoaka T; Nishizawa T; Suzuki M; Ito M; Kurihara N; Omata F; Mizuno S; Torii A; Kawakami K; Ohkusa T; Tokunaga K; Mine T; Sakaki N
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():29-32. PubMed ID: 25521730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
    Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.
    Kim JS; Kim BW; Hong SJ; Kim JI; Shim KN; Kim JH; Baik GH; Kim SW; Song HJ; Kim JH
    Gut Liver; 2016 Jul; 10(4):556-61. PubMed ID: 27114421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
    Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
    Park SM; Kim JS; Kim BW; Ji JS; Choi H
    J Gastroenterol Hepatol; 2017 Mar; 32(3):589-594. PubMed ID: 27505301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14-day regimen?
    Zullo A; Fiorini G; Scaccianoce G; Portincasa P; De Francesco V; Vassallo R; Urban F; Monica F; Mogavero G; Amato A; Vaira D
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):11-14. PubMed ID: 30851166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
    Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
    Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
    Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
    Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
    Wu DC; Hsu PI; Wu JY; Opekun AR; Kuo CH; Wu IC; Wang SS; Chen A; Hung WC; Graham DY
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):36-41.e1. PubMed ID: 19804842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
    Heo J; Jeon SW; Jung JT; Kwon JG; Lee DW; Kim HS; Yang CH; Park JB; Park KS; Cho KB; Lee SH; Jang BI;
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1361-6. PubMed ID: 25867608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea].
    Choi WH; Park DI; Oh SJ; Baek YH; Hong CH; Hong EJ; Song MJ; Park SK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 May; 51(5):280-4. PubMed ID: 18516011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.